Company intelligence / Profile preview

Adeste

São Paulo, São Paulo, Brazil

Ownership: Private
Employees: ~900
Development stage: Other

Overview

Adeste is a global leader in the production of key animal-derived active pharmaceutical ingredients, notably bovine heparin (anticoagulant, approved and globally marketed), chondroitin sulfate (cartilage/joint health, globally commercialized), fetal bovine serum (cell culture, for research, vaccines), and absorbable sutures (commercial surgical use). Clinical results for these products are established and form standard of care in their respective uses.

Therapeutic areas: NephrologyRheumatologyCardiovascularOther
Modalities: BiologicProteinSmall molecule
Industry: Chemicals & Materials

Partnerships

Nintx (Brazilian biotech, joint drug discovery partnership)

Beyond the preview

Go deeper on Adeste.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adeste.

Explore the full profile